COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1567: Articles 15661-15670  | Next

Clumpiness: Modeling the Impact of Social Dynamics on COVID-19 Spread
Goertzel, B., Pennachin, C., Duong, D., Ikle, M., Duncan, M., Boyd, J., Senna, A., Duraes, R.
10.1101/2021.04.12.21255149 — Posted: 2021-04-16
Evaluating the impact of keeping indoor dining closed on COVID-19 rates among large US cities: a quasi-experimental design
Schnake-Mahl, A. S., O'Leary, G., Mullachery, P., Vaidya, V., Connor, G., Rollins, H., Kolker, J., Diez Roux, A. V., Bilal, U.
10.1101/2021.04.12.21251656 — Posted: 2021-04-16
A very simple model to account for the rapid rise of the British variant of SARS-CoV-2 in several countries and the world
Fort, H.
10.1101/2021.04.13.21254841 — Posted: 2021-04-16 Discussion: Onsite
Preparations of Dutch emergency departments for the COVID-19 pandemic: a questionnaire-based study
O' Connor, R. D., Barten, D. G., Latten, G. H.
10.1101/2021.04.10.21254878 — Posted: 2021-04-16
Strong anti-viral responses in pediatric COVID-19 patients in South Brazil
Fazolo, T., Lima, K., Fontoura, J. C., Souza, P. O. d., Hilario, G., Zorzetto, R., Rodrigues, L., Pscheidt, V. M., Ferreira Neto, J., Haubert, A. F., Gambin, I., Oliveira, A. C., Mello, R. S., Gutierrez, M., Gassen, R. B., Sauthier Sartor, I. T., Zavaglia, G. O., Fernandes, I. R., Varela, F. H., Polese-Bonatto, M., Borges, T. J., Callegari-Jacques, S. M., da Costa, M. S. C., Schwartz, J. d. A., Scotta, M. C., Stein, R. T., Bonorino, C.
10.1101/2021.04.13.21255139 — Posted: 2021-04-16
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation
Serra, A., Fratello, M., Federico, A., Ojha, R., Provenzani, R., Tasnadi, E., Cattelani, L., del Giudice, G., Kinaret, P. A. S., Saarimaki, L. A., Pavel, A., Cerullo, V., Vapalahti, O., Horvath, P., Di Lieto, A., Yli-Kauhaluoma, J., Balistreri, G., Greco, D.
10.1101/2021.04.15.440004 — Posted: 2021-04-15
Time-series trend of pandemic SARS-CoV-2 variants visualized using batch-learning self-organizing map for oligonucleotide compositions
Abe, T., Furukawa, R., Iwasaki, Y., Ikemura, T.
10.1101/2021.04.15.439956 — Posted: 2021-04-15
Multi-modal engineering of Bst DNA polymerase for thermostability in ultra-fast LAMP reactions
Paik, I., Ngo, P. H. T., Shroff, R., Maranhao, A. C., Walker, D. J. F., Bhadra, S., Ellington, A.
10.1101/2021.04.15.439918 — Posted: 2021-04-15 Discussion: Onsite
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered Komagataella phaffii
Dalvie, N. C., Biedermann, A. M., Rodriguez-Aponte, S. A., Naranjo, C. A., Rao, H. D., Rajurkar, M. P., Lothe, R. R., Shaligram, U. S., Johnston, R. S., Crowell, L. E., Castelino, S., Tracey, M. K., Whittaker, C. A., Love, J. C.
10.1101/2021.04.15.440035 — Posted: 2021-04-15
Evaluation of the SARS-CoV-2 inactivation efficacy associated with buffers from three kits used on high-throughput RNA extraction platforms
Thom, R. E., Eastaugh, L., O'Brien, L., Ulaeto, D., Findlay, J. S., Smither, S., Phelps, A., Stapleton, H., Hamblin, K. A., Weller, S. A.
10.1101/2021.04.14.439928 — Posted: 2021-04-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).